Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
7
×
life sciences
national
national blog main
national top stories
raleigh-durham blog main
raleigh-durham top stories
7
×
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
cancer
ipo
novartis
biogen
celgene
gene therapy
non-hodgkin lymphoma
vc
boehringer ingelheim
cancer immunotherapy
democrats
What
ipo
7
×
bio
life
roundup
science
week
firms
new
public
biogen
biotechs
cancer
companies
company
developing
investors
million
therapeutics
activity
allogene
america
approvals
arena’s
blood
bounty
broader
chose
cig
clamped
close
club
comeback
continued
continues
convoluted
corner
covid
crispr
crop
deals
Language
unset
Current search:
ipo
×
" raleigh-durham top stories "
×
" boston top stories "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M